article thumbnail

Invest in Israel Newsletter – February 2012

VC Cafe

Check-Cap plans to raise another $20-25 million in a private placement with the support of Citigroup Inc. Check-Cap will use the proceeds to carry out clinical trials and, pending their success, plans to begin marketing its ingestible and disposable 3D colon imaging capsule in Europe in 2013.

Flash 94
article thumbnail

Invest in Israel Newsletter – February 2012

VC Cafe

Check-Cap plans to raise another $20-25 million in a private placement with the support of Citigroup Inc. Check-Cap will use the proceeds to carry out clinical trials and, pending their success, plans to begin marketing its ingestible and disposable 3D colon imaging capsule in Europe in 2013.

Flash 60